Novavax COVID-19 vaccine
== Novavax COVID-19 Vaccine ==
The Novavax COVID-19 vaccine, also known as NVX-CoV2373, is a protein subunit vaccine developed by Novavax for the prevention of COVID-19. The vaccine is designed to stimulate an immune response against the SARS-CoV-2 virus, which causes COVID-19.
Development and Approval[edit]
The development of the Novavax COVID-19 vaccine began in early 2020. The vaccine uses a recombinant nanoparticle technology to generate an immune response. It includes a Matrix-M adjuvant to enhance the body's immune response to the vaccine.
In clinical trials, the Novavax vaccine demonstrated high efficacy in preventing symptomatic COVID-19 infection. It has been authorized for emergency use in several countries and is under review by various health authorities worldwide.
Mechanism of Action[edit]
The Novavax COVID-19 vaccine works by introducing a protein subunit of the SARS-CoV-2 virus into the body. This protein is harmless on its own but is recognized by the immune system as a foreign invader. The immune system then produces antibodies and trains T cells to recognize and fight the actual virus if the person is exposed in the future.
Administration[edit]
The vaccine is administered as an intramuscular injection, typically in two doses given several weeks apart. The exact schedule may vary based on regulatory guidelines and ongoing research.
Efficacy and Safety[edit]
Clinical trials have shown that the Novavax COVID-19 vaccine is highly effective in preventing COVID-19, including severe disease and hospitalization. Common side effects include pain at the injection site, fatigue, headache, and muscle pain. These side effects are generally mild and resolve within a few days.
Storage and Distribution[edit]
The Novavax vaccine can be stored at standard refrigerator temperatures, making it easier to distribute compared to some other COVID-19 vaccines that require ultra-cold storage.
Related Pages[edit]
See Also[edit]
- Pfizer–BioNTech COVID-19 vaccine
- Moderna COVID-19 vaccine
- Johnson & Johnson COVID-19 vaccine
- AstraZeneca COVID-19 vaccine
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
